Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Cardiol Therapeutics Inc. (CRDL) vs Sofgen Pharma S.A (PROCF)

Cardiol Therapeutics Inc. and Sofgen Pharma S.A are both Drug Manufacturers Specialty & Generic companies. Cardiol Therapeutics Inc. is the larger, with a market value of $202.1M against $114.0M — 1.8× the size. Sofgen Pharma S.A has the higher net margin (9.52% vs 0.00%) and the higher return on invested capital (15.2% vs 0.00%). Across the 13 metrics below, Sofgen Pharma S.A leads on 10 and Cardiol Therapeutics Inc. on 3.

Valuation

Metric CRDL PROCF Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m n/m 2.25
P/B 11.32 n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m 3.29 12.29
EV/Sales n/m 0.70 2.56
Earnings yield (14.62%) 0.00% (2.99%)
Free cash flow yield (8.77%) 0.00% 0.00%

Profitability

Metric CRDL PROCF Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 56.16% 53.94%
Operating margin 0.00% 17.01% 0.00%
Net margin 0.00% 9.52% 0.00%
Free cash flow margin 0.00% 17.66% 0.00%
Return on equity (171.13%) (213.06%) (0.40%)
Return on assets (124.40%) 8.82% (3.32%)
Return on invested capital 0.00% 15.21% 0.00%

Growth

Metric CRDL PROCF Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 5.10% 10.01%
EPS growth (last fiscal year) 24.32% (270.30%) —
Revenue growth, 5-year CAGR — (1.82%) 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRDL PROCF Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 (435.78) 0.05
Current ratio 5.55 0.64 2.31
Net debt to EBITDA 0.62 (7.21) 0.85

Dividend

Metric CRDL PROCF Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric CRDL PROCF Drug Manufacturers Specialty & Generic median
Market cap 202.10m 113.95m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack